Results 171 to 180 of about 32,075 (207)

The 19th EURL-AR Proficiency Test Salmonella, Campylobacter and genotypic characterisation 2015 [PDF]

, 2016
Aarestrup, Frank Møller, Cavaco, Lina, Hendriksen, Rene S., Karlsmose Pedersen, Susanne   +3 more
core  

Real-world clinical effectiveness of trimethoprim-sulfamethoxazole for primary prophylaxis of pneumocystis pneumonia in non-hodgkin lymphoma patients treated with rituximab. [PDF]

PLoS One
Charoenrit P, Niparuck P, Rotjanapan P.
europepmc   +1 more source

Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients. [PDF]

J Comp Eff Res
Madaras-Kelly K, Boyd J, Bond L.
europepmc   +1 more source

Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients. [PDF]

BMC Infect Dis
Xie J, Gao A, Zhang W, Zhao D, Liu W.
europepmc   +1 more source

Pneumocystis jirovecii pneumonia in a patient with Mycobacterium intracellulare pulmonary disease: a case report. [PDF]

BMC Infect Dis
Zhou X, Xiao X, Wu Y, Wang J, Pan Z, Wang H, Luo X, Yao Z.   +7 more
europepmc   +1 more source

Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023.

MMWR Morb Mortal Wkly Rep
Logan N, Birhane MG, McDonald SL, Alarcón J, Amador S, Anand M, Bachmann LH, Bernard K, Black LS, Chen AN, Cooley LA, Fortes ED, Gerard M, Jervis RH, Kimura AC, Lamba K, Latash J, Li L, Pederson G, Kauffman CP, Reynolds JL, Santiago R, Siemetzki-Kapoor U, Smole SC, Tagg KA, Vostok J, Webb HE, Francois Watkins LK, XDR Shigella Working Group.   +28 more
europepmc   +1 more source

Occurrence of Pharmaceuticals in the Seawater Samples of the Port of Cartagena (Murcia, Spain): A Pilot Study. [PDF]

Toxics
Badillo E, Yuste MT, Vallejo F, Escudero E, Poapolathep A, Poapolathep S, Marín P.   +6 more
europepmc   +1 more source

Phenotypic and genomic profiling of multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolated from Intensive Care Unit patients in Kenya. [PDF]

BMC Microbiol
Oduor B, Maina A, Mwale J, Ogoti B, Otieno L, Jepleting M, Ayodo C, Mugoh R, Ita T, Kuja J, Omulo S.   +10 more
europepmc   +1 more source

Unlocking the potential of <i>Pseudomonas aeruginosa</i> QS intermediates as antimicrobial synergists against three multidrug-resistant enteric bacteria. [PDF]

Front Microbiol
Kiran S, Alhegaili AS, Al-Dayan N, Naseem Z, Siddique W, Ayoub I, Iqbal S, Jabeen S, Habib FE, Taj S, Hussain A, Bashir R, Sarwar Y, Ali A, Rauf W, Jander G, Iqbal M.   +16 more
europepmc   +1 more source